TYPICAL AND ATYPICAL PRESENTATION OF COVID-19 INFECTION IN CHILDREN IN THE TOP OF PANDEMIC IN MINIA GOVERNORATE (TWO CENTER EXPERIENCE)

Main Article Content

Madeha Abdalla Sayed
Mohamed Abdelhakeem

Keywords

Keywords:COVID-19 Infection, Children, Minia Governorate.

Abstract

Back ground: A novel coronavirus which is identified as cause of pandemic situation inFebruary2020 and affecting adult and children with variable presentation and outcome.


Objective: We studied the typical and atypical clinical and laboratory presentation of COVID-19 during the peak of the first wave   in two main  referral hospitals, upper Egypt El Minya governorate.


Methods:  Among 88 children with suspected cases  tested for COVID-19, only 22 who proved to be  positive. Studied patients were classified into 3 groups based on age. The first group 2–5years,the second for 5–10years and the third one included those aged more than 10 years. All patients met diagnostic guidelines established by Egyptian Ministry of health.


Results: out of the positive 22 (25%) patients, 13(59.1%) of them were male, while 9 (40.9%) were females. All enrolled patients have a history of near contact exposure (100%). Thrombocytopenia was the highest presenting symptom in all enrolled patients18(81.8%), while other hematological findings were anemia in 11 (50%), thrombotic symptoms in 2(9.1%), pancytopenia in 2(9.1%) while bleeding was found in 1 patient (4.5%) .Fever 16 (72.7%) the common constitutional symptoms in COVID-19 were not reported in all enrolled patients (0%) while sore throat was reported in only 2 patients (9.1%).Respiratory presentation was only dominant in positive chest CT finding rather than clinical symptoms 17(72.3%) GIT symptom were the dominant presenting feature as vomiting was found in 15 (68.2%), diarrhea in 10 (45.5%), abdominal pain in 11 (50%), jaundice in 9 (40.9%) and dehydration in 6 (27.3%).Neurological symptoms were convulsions in 4(18.2%) while encephalopathy was 2(9.1%).Nephritis was the only renal presentation in the enrolled patients3 (13.6%).Cardiac presentations were only cyanosis 8 (36.4%) and arrhythmias 6 (27.3%)


Conclusion: COVID-19 has many clinical  classic presentation in children  however  other non-typical presentation like hematological. CNS and renal presentation has been reported. 


 

Downloads

Download data is not yet available.
Abstract 525 | PDF Downloads 119 HTML Downloads 30

References

1. Singh A, Shaikh A, Singh R, Singh AK. COVID-19: From bench to bed side. Diabetes Metab Syndr. 2020;14:277-281.

2. Wang H, Li X, Li T, Zhang S, Wang L, Wu X, Liu J. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020;39:1629-1635.


3. 19 (SARS‐CoV‐2 INFECTION) (Study Of Scientific Board) General Information, Epidemiology and Diagnosis (online). https://hsgm.saglik.gov.tr/depo/covid19/Ingilizce/Rehber/COVI19_Rehberi__Genel_bilgiler_epidemiyoloji_ve_tani_8.06.2020_eng.pdf Accessed July 2, 2020

4. Wang, D.; Hu, B.; Hu, C.; Zhu, F.; Liu, X.; Zhang, J.; Wang, B.; Xiang, H.; Cheng, Z.; Xiong, Y.; et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. J. Am. Med. Assoc. 2020, 323, 1061–1069.


5. Ludvigsson, J.F. Systematic Review of Covid-19 in Children Shows Milder Cases and a Better Prognosis Than Adults. Acta Paediatr. 2020, 109, 1088–1095.

6. Wu, Z.; McGoogan, J.M. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (Covid-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. J. Am. Med. Assoc. 2020, 323, 1239–1242.

7. Philips CA, Mohan N, Ahamed R, Kumbar S, Rajesh S, George T, Mohanan M, Augustine P. One disease, many faces-typical and atypical presentations of SARS-CoV-2 infection-related COVID-19 disease. World J Clin Cases 2020; 8(18): 3956-3970.

8. Caruso, D.; Zerunian, M.; Polici, M.; Pucciarelli, F.; Polidori, T.; Rucci, C.; Guido, G.; Bracci, B.; De Dominicis, C.; Laghi, A. Chest Ct Features of Covid-19 in Rome, Italy. Radiology 2020, 296, 201237.


9. Caro-Dominguez, P.; Shelmerdine, S.C.; Toso, S.; Secinaro, A.; Toma, P.; Damasio, M.B.; Navallas, M.; Riaza-Martin, L.; Gomez-Pastrana, D.; Mahani, G.M.; et al. Thoracic Imaging of Coronavirus Disease 2019 (Covid-19) in Children: A Series of 91 Cases. Pediatr. Radiol. 2020, 50, 1354–1368.

10. Liu, R.; Han, H.; Liu, F.; Lv, Z.; Wu, K.; Liu, Y.; Feng, Y.; Zhu, C. Positive Rate of RT-PCR Detection of Sars-Cov-2 Infection in 4880 Cases from One Hospital in Wuhan, China, from Jan to Feb 2020. Clin. Chim. Acta 2020, 505, 172–175.

11. Liu, X.; Feng, J.; Zhang, Q.; Guo, D.; Zhang, L.; Suo, T.; Hu, W.; Guo, M.; Wang, X.; Huang, Z.; et al. Analytical Comparisons of Sars-Cov-2 Detection by qRT-PCR and ddPCR with Multiple Primer/Probe Sets. Emerg. Microbes Infect. 2020, 9, 1175–1179.

12. Ricco, M.; Ferraro, P.; Gualerzi, G.; Ranzieri, S.; Henry, B.M.; Said, Y.B.; Pyatigorskaya, N.V.; Nevolina, E.; Wu, J.; Bragazzi, N.L.; et al. Point-of-Care Diagnostic Tests for Detecting Sars-Cov-2 Antibodies: A Systematic Review and Meta-Analysis of Real-World Data. J. Clin. Med. 2020, 9, 1515.

13. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145(6):e20200702.


14. Götzinger F, Santiago-García B, Noguera-Julián A, et al. COVID-19 in Children and Adolescents in Europe: A Multinational, Multicentre Cohort Study. Lancet Child Adolesc Health. 2020;4(9):653-661

15. Teherani MF, Kao CM, Camacho-Gonzalez A, et al. Burden of Illness in Households With Severe Acute Respiratory Syndrome Coronavirus 2–Infected Children. J Pediatric Infect Dis Soc. 2020;9(5):613–616.

16. Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr. 2020;174(9):868-873.


17. Mannheim J, Gretsch S, Layden JE, Fricchione MJ. Characteristics of Hospitalized Pediatric Coronavirus Disease 2019 Cases in Chicago, Illinois, March-April 2020. J Pediatric Infect Dis Soc. 2020;9(5):519-522.

18. Assaker R, Colas A-E, Julien-Marsollier F, et al. Presenting Symptoms of COVID-19 in Children: A Meta-Analysis of Published Studies. Br J Anaesth. 2020;125(3):e330-e332. doi:10.1016/j.bja.2020.05.026external icon.

19. Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39:355–368.

20. Bixler D, Miller AD, Mattison CP, et al. SARS-CoV-2–Associated Deaths Among Persons Aged <21 Years — United States, February 12–July 31, 2020. MMWR. 2020;69:1324–1329.
21. Leeb RT, Price S, Sliwa S, et al. COVID-19 Trends Among School-Aged Children — United States, March 1–September 19, 2020. MMWR. 2020;69:1410–1415.

22. Mao R, Qiu Y, He J-S, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. May 17,2020
23. Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607–1608.
24. Xu Z , Shi L , Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome.Lancet Respir Med. 2020; 8: 420-422.
25. Fan Z , Chen L , Li J , et al.Clinical features of COVID-19 related liver damage.medRxiv. 2020.

26. Clerkin K.J, Fried J.A, Raikhelkar J, et al.Coronavirus disease 19 (Covid-19) and cardiovascular disease.Circulation. 2020; 141: 1648-1655

27. Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19.N Engl J Med. 2020; 382: e38

28. Jiang T, Gao L, Lu J, et al.ACE2-Ang-(1-7)-Mas axis in brain: a potential target for prevention and treatment of ischemic stroke.Curr Neuropharm. 2013; 11: 209-217.

29. Terpos E, Ntanasis‐Stathopoulos I. Hematological findings and complications of COVID‐19. Am J Hematol. 2020; 95: 834‐ 847.

30. Mantovani A, Rinaldi E, Zusi C, Beatrice G, Saccomani MD, Dalbeni A. Coronavirus disease 2019 (COVID‐19) in children and/or adolescents: a meta‐analysis. Pediatr Res. 2020

31. Castagnoli R, Votto M, Licari A, et al. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection in children and adolescents: a systematic review. JAMA Pediatr. 2020; 174(9): 882‐ 889.

32. Toubiana J, Poirault C, Corsia A, et al. Kawasaki‐like multisystem inflammatory syndrome in children during the covid‐19 pandemic in Paris, France: prospective observational study. BMJ. 2020; 369:m2094.

33. Fletcher‐Sandersjöö A, Bellander BM. Is COVID‐19 associated thrombosis caused by overactivation of the complement cascade? A literature review. Thromb Res. 2020; 194: 36‐ 41.

34. Nakazawa F, Kannemeier C, Shibamiya A, et al. Extracellular RNA is a natural cofactor for the (auto‐)activation of Factor VII‐activating protease (FSAP). Biochem J. 2005; 385: 831‐ 838.

35. Kannemeier C, Shibamiya A, Nakazawa F, et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A. 2007; 104: 6388‐ 6393.
36. Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A. 2010; 107: 15880‐ 15885.

37. Loi M, Branchford B, Kim J, Self C, Nuss R. COVID‐19 anticoagulation recommendations in children. Pediatr Blood Cancer. 2020; 67(9):e28485.

38. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. Published online March 23, 2020.
39. Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.

40. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062.